Literature DB >> 414196

Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn.

J Pollock, F Kiechel, D Cooper, M Weinberger.   

Abstract

Exercise-induced bronchospasm was induced by treadmill running in 12 children on two days preceding either inhaled cromolyn sodium (Intal) or oral theophylline (Slo-Phyllin tablets), 7.5 mg/kg, administered in a double-blind manner. A second exercise period identical to the first followed two hours later; the medication administration had been timed so that the second exercise stress followed two hours after theophylline administration and 15 minutes following cromolyn administration. The patients subsequently were exercised twice more at two-hour intervals on both days. Blood was drawn from serum theophylline measurement immediately after each of the exercise periods. There was little demonstrable exercise-induced bronchospasm resulting from the first postmedication exercise period following theophylline administration. The two subsequent exercise periods were associated with some return of postexercise bronchospasm. The degree of inhibition of exercise-induced bronchospasm correlated with serum theophylline levels that averaged 16, 13, and 10 microgram/ml at two, four and six hours after the theophylline dose (mean Spearman rank correlation coefficient = .71, P less than .01). The effect of cromolyn in suppression exercise-induced bronchospasm that matched or excelled that seen with theophylline.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 414196

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

Review 1.  Asthmatic drugs and competitive sport. An update.

Authors:  A R Morton; K D Fitch
Journal:  Sports Med       Date:  1992-10       Impact factor: 11.136

2.  Current state of theophylline in asthma.

Authors:  S McKenzie
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

Review 3.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 4.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

5.  Diffusion and flow transfer of theophylline across the blood-brain barrier: pharmacokinetic analysis.

Authors:  M D Karol; P Veng-Pedersen; R E Brashear
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

Review 6.  Exercise-induced asthma.

Authors:  P A Eggleston
Journal:  Clin Rev Allergy       Date:  1983-03

7.  Trial of cromoglycate and slow-release aminophylline in perennial childhood asthma.

Authors:  M Weinberger; G Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-06

8.  Dosage guidelines for slow-release aminophylline in childhood asthma.

Authors:  I Blumenthal; D Berry
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

9.  Slow-release theophylline preparations.

Authors:  M Weinberger
Journal:  Arch Dis Child       Date:  1979-07       Impact factor: 3.791

Review 10.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.